Skip to main content
. 2014 Jan 29;99(4):1314–1321. doi: 10.1210/jc.2013-4086

Table 5.

Ovarian Steroids After Subcutaneous hCG Injection in Normal and Obese Womena

Analyte Time Point (hours) Normal (n = 11) Obese (n = 11) P Valueb
Estradiol, pg/mL 0 107.5 (55.7–205.3) 79.2 (60.8–101.4) .11
36 67.4 (58.5–106.2) 74.7 (71.5–132.2)
    P valuec .16 .03
Progesterone, ng/mL 0 0.4 (0.2–0.5) 0.8 (0.4–2.4) .18
36 0.5 (0.3–0.9) 0.6 (0.4–6.1)
    P valuec .08 .10
T, ng/dL 0 31.8 (17.7–45.1) 35.8 (21.0–42.6) .32
36 38.5 (33.6–43.4) 41.6 (26.0–49.9)
    P valuec .31 .04
SHBG, nmol/L 0 58.8 (43.6–102.4) 47.7 (27.0–68.9) .03
36 75.2 (52.4–113.4) 51.7 (28.5–78.0)
    P valuec .06 .02
17-OHP, ng/dL 0 25.0 (20.0–47.5) 31.0 (12.5–43.5) .71
36 89.0 (57.0–121.0) 78.0 (64.0–156.0)
    P valuec .001 .001
DHEA, ng/dL 0 92.0 (66.0–181.5) 204.0 (129.5–267.0) .24
36 124.5 (65.0–151.5) 158.0 (107.0–193.5)
    P valuec .64 .03
a

Results are expressed as median (interquartile range).

b

P values comparing normal with obese women were calculated using Wilcoxon rank sum (Mann-Whitney U) tests.

c

P values comparing responses from baseline with 36 hours within a weight class were calculated using Wilcoxon signed rank tests.